Your browser doesn't support javascript.
Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India.
Mahapatra, Amarendra; Palo, Subrata Kumar; Bhattacharya, Debdutta; Kanungo, Srikanta; Kshatri, Jaya Singh; Mishra, Bijaya Kumar; Mansingh, Asit; Parai, Debaprasad; Pattnaik, Matrujyoti; Choudhary, Hari Ram; Dash, Girish Chandra; Mohanta, Amiya Ranjan; Bishoyee, Anjan; Mohanty, Prasantajyoti; Mandal, Nityananda; Dayal, Rakesh; Mitra, Anindya; Pati, Sanghamitra.
  • Mahapatra A; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Palo SK; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Bhattacharya D; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Kanungo S; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Kshatri JS; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mishra BK; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mansingh A; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Parai D; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Pattnaik M; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Choudhary HR; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Dash GC; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mohanta AR; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Bishoyee A; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mohanty P; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Mandal N; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Dayal R; Department of State TB Training and Demonstration Centre, National Health Mission, Government of Jharkhand, Ranchi, Jharkhand, India.
  • Mitra A; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
  • Pati S; ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
Indian J Med Res ; 156(2): 228-239, 2022 08.
Article in English | MEDLINE | ID: covidwho-2110459
ABSTRACT
Background &

objectives:

Serosurvey of COVID-19 provides a better estimation of people who have developed antibodies against the infection. Undertaking such a serosurvey in certain districts of India which are densely populated with prominent tribes can provide valuable information regarding seropravelance of SARS-CoV-2 antibodies among such indigenous populations. In this context, two rounds of population-based, cross-sectional serosurveys for SARS-CoV-2 IgG antibody were carried out in Jharkhand, a tribal-dominated State of India, to compare the seroprevalence of SARS-CoV-2 infection and to determine the associated demographic risk factors.

Methods:

The surveys were carried out in June 2020 and February 2021 in ten districts of the State of Jharkhand. Blood samples were collected from the residents of the selected districts by random sampling and tested for anti-SARS-CoV-2 antibodies using an automated chemiluminescence immunoassay platform. A total of 4761 and 3855 eligible participants were included in round 1 and round 2, respectively.

Results:

The age- and gender-standardized seroprevalence for COVID-19 during round 1 was 0.54 per cent (0.36-0.80) that increased to 41.69 per cent (40.16-43.22) during round 2 with a gap of eight months in between. The seropositivity among male and female participants was 0.73 and 0.45 per cent, respectively, during the first round and 51.35 and 33.70 per cent, respectively, during the second round. During the first round, 17.37 per cent of the participants were tribal with seropositivity of 0.24 per cent (0.02-0.87), and during the second round, 21.14 per cent were tribal with seropositivity of 39.14 per cent (35.77-42.59). Compared to tribal group, non-tribal participants had an adjusted odds of 1.24 (95% confidence interval=1.04-1.48) for SARS-CoV-2 seropositivity. Interpretation &

conclusions:

COVID-19 seroprevalence was found to be low during the first round (0.54%) of the survey, possibly due to the travel restrictions during lockdown better adherence to social distancing and wearing of face masks among the people. Understanding the dynamics of SARS-CoV-2 transmission and the susceptibility to infection at the individual as well as community level will inform decision and help policy makers to design and implement effective public health strategies to mitigate the pandemic in this State.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Indian J Med Res Year: 2022 Document Type: Article Affiliation country: Ijmr.ijmr_3040_21

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Indian J Med Res Year: 2022 Document Type: Article Affiliation country: Ijmr.ijmr_3040_21